- Report
- July 2026
- 160 Pages
Global
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- April 2026
- 160 Pages
Global
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- April 2026
- 160 Pages
Global
From €3064EUR$3,320USD£2,565GBP
€3830EUR$4,150USD£3,207GBP
- Report
- January 2026
- 160 Pages
Global
From €2916EUR$3,160USD£2,442GBP
€3645EUR$3,950USD£3,052GBP
- Report
- January 2026
- 160 Pages
Global
From €2916EUR$3,160USD£2,442GBP
€3645EUR$3,950USD£3,052GBP
- Report
- January 2026
- 160 Pages
Global
From €2916EUR$3,160USD£2,442GBP
€3645EUR$3,950USD£3,052GBP
- Report
- April 2026
- 108 Pages
Global
From €3500EUR$4,062USD£3,033GBP
- Report
- April 2026
- 120 Pages
Global
From €3500EUR$4,062USD£3,033GBP
- Report
- April 2026
- 95 Pages
Global
From €3500EUR$4,062USD£3,033GBP
- Report
- April 2026
- 122 Pages
Global
From €3500EUR$4,062USD£3,033GBP
- Report
- March 2026
- 181 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2026
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- April 2026
- 783 Pages
Global
From €4610EUR$4,995USD£3,860GBP
- Report
- April 2026
- 155 Pages
Global
From €4610EUR$4,995USD£3,860GBP
- Report
- February 2026
Global
From €6922EUR$7,500USD£5,795GBP
- Report
- December 2025
- 53 Pages
Global
From €6922EUR$7,500USD£5,795GBP
- Report
- February 2026
- 70 Pages
United States
From €4610EUR$4,995USD£3,860GBP
- Report
- January 2024
- 251 Pages
Global
From €5377EUR$6,030USD£4,350GBP
- Report
- January 2023
- 330 Pages
Global
From €4883EUR$5,476USD£3,950GBP
- Report
- December 2022
- 250 Pages
Global
From €4883EUR$5,476USD£3,950GBP

The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression, addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less Read more